Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
12.21
+0.29 (2.43%)
At close: Jul 25, 2025, 4:00 PM
12.37
+0.16 (1.31%)
After-hours: Jul 25, 2025, 4:06 PM EDT

Ocular Therapeutix Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
1,9451,3434922165341,559
Upgrade
Market Cap Growth
-13.82%173.13%127.16%-59.47%-65.74%720.77%
Upgrade
Enterprise Value
1,6729914641554131,546
Upgrade
Last Close Price
12.218.544.462.816.9720.70
Upgrade
PS Ratio
34.3121.078.414.2012.2789.57
Upgrade
PB Ratio
7.314.265.396.126.0720.48
Upgrade
P/TBV Ratio
7.314.265.396.126.0720.48
Upgrade
EV/Sales Ratio
28.0215.547.943.019.5088.85
Upgrade
Debt / Equity Ratio
0.290.240.921.820.670.77
Upgrade
Asset Turnover
0.130.180.290.290.190.10
Upgrade
Inventory Turnover
53.1649.8631.0135.9844.4628.56
Upgrade
Quick Ratio
9.8910.276.363.947.049.01
Upgrade
Current Ratio
10.2210.666.664.137.269.23
Upgrade
Return on Equity (ROE)
-57.19%-95.21%-127.64%-115.16%-7.99%-429.55%
Upgrade
Return on Assets (ROA)
-27.21%-30.53%-25.66%-27.76%-20.90%-23.06%
Upgrade
Return on Capital (ROIC)
-31.18%-38.31%-37.56%-39.86%-34.65%-41.29%
Upgrade
Earnings Yield
-9.91%-14.41%-16.42%-32.83%-1.23%-9.98%
Upgrade
FCF Yield
-7.63%-10.13%-15.53%-29.26%-12.50%-3.49%
Upgrade
Buyback Yield / Dilution
-79.29%-84.90%-3.57%-0.59%-35.24%-34.19%
Upgrade
Updated May 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q